97 related articles for article (PubMed ID: 10064067)
1. Ability of macrophage subsets to transfer resistance to murine leishmaniasis is dependent on IL-12 production.
Doherty TM; Coffman RL
Eur J Immunol; 1999 Feb; 29(2):522-9. PubMed ID: 10064067
[TBL] [Abstract][Full Text] [Related]
2. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
Doherty TM; Coffman RL
J Immunol; 1993 Jun; 150(12):5476-83. PubMed ID: 8515072
[TBL] [Abstract][Full Text] [Related]
3. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility or resistance to Leishmania infection is dictated by the macrophages evolved under the influence of IL-3 or GM-CSF.
Saha B; Saini A; Germond R; Perrin PJ; Harlan DM; Davis TA
Eur J Immunol; 1999 Jul; 29(7):2319-29. PubMed ID: 10427995
[TBL] [Abstract][Full Text] [Related]
5. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis.
Guler R; Afshar M; Arendse B; Parihar SP; Revaz-Breton M; Leitges M; Schwegmann A; Brombacher F
Eur J Immunol; 2011 Mar; 41(3):706-15. PubMed ID: 21287553
[TBL] [Abstract][Full Text] [Related]
6. Leishmania major: targeting IL-4 in successful immunomodulation of murine infection.
Wakil AE; Wang ZE; Locksley RM
Exp Parasitol; 1996 Nov; 84(2):214-22. PubMed ID: 8932771
[TBL] [Abstract][Full Text] [Related]
7. Regulation of macrophage IL-12 synthesis by Leishmania phosphoglycans.
Piedrafita D; Proudfoot L; Nikolaev AV; Xu D; Sands W; Feng GJ; Thomas E; Brewer J; Ferguson MA; Alexander J; Liew FY
Eur J Immunol; 1999 Jan; 29(1):235-44. PubMed ID: 9933105
[TBL] [Abstract][Full Text] [Related]
8. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
9. IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Scharton-Kersten T; Afonso LC; Wysocka M; Trinchieri G; Scott P
J Immunol; 1995 May; 154(10):5320-30. PubMed ID: 7730635
[TBL] [Abstract][Full Text] [Related]
10. Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with
Hu S; Marshall C; Darby J; Wei W; Lyons AB; Körner H
Front Immunol; 2018; 9():1. PubMed ID: 29403488
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection.
Ota H; Takashima Y; Matsumoto Y; Hayashi Y; Matsumoto Y
J Vet Med Sci; 2008 Jun; 70(6):589-93. PubMed ID: 18628599
[TBL] [Abstract][Full Text] [Related]
12. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
Bretscher PA; Ogunremi O; Menon JN
Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
14. Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasis.
Schönlau F; Schlesiger C; Ehrchen J; Grabbe S; Sorg C; Sunderkötter C; Ehrehen J
J Leukoc Biol; 2003 May; 73(5):564-73. PubMed ID: 12714570
[TBL] [Abstract][Full Text] [Related]
15. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major.
Flohé SB; Bauer C; Flohé S; Moll H
Eur J Immunol; 1998 Nov; 28(11):3800-11. PubMed ID: 9842923
[TBL] [Abstract][Full Text] [Related]
16. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
17. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity.
Kamanaka M; Yu P; Yasui T; Yoshida K; Kawabe T; Horii T; Kishimoto T; Kikutani H
Immunity; 1996 Mar; 4(3):275-81. PubMed ID: 8624817
[TBL] [Abstract][Full Text] [Related]
18. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells.
Belkaid Y; Butcher B; Sacks DL
Eur J Immunol; 1998 Apr; 28(4):1389-400. PubMed ID: 9565379
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
Scott P
J Immunol; 1991 Nov; 147(9):3149-55. PubMed ID: 1833466
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication.
Vieira LQ; Goldschmidt M; Nashleanas M; Pfeffer K; Mak T; Scott P
J Immunol; 1996 Jul; 157(2):827-35. PubMed ID: 8752935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
